Skip to main content
SpringerLink
Log in

UK MHRA recalls contaminated losartan, irbesartan batches

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Bristol Laboratories Limited, Brown & Burk UK Ltd, and Teva UK Ltd.

Reference

  • Medicines and Healthcare products Regulatory Agency (UK). Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14. Internet Document : 17 Jun 2021. Available from: URL: https://www.gov.uk/drug-device-alerts/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

UK MHRA recalls contaminated losartan, irbesartan batches. Reactions Weekly 1863, 6 (2021). https://doi.org/10.1007/s40278-021-98610-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-98610-1

Search

Navigation